Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70 (0.87%) Dr. Reddys Laboratories informs about press release
Date: 11-08-2020Dr. Reddys Laboratories has informed that it has enclosed a Press Release on 11th August 2020 ‘Dr. Reddy's Laboratories announces the First-to Market launch of the generic version of Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension, USP in the U.S. Market’.
The above information is a part of company’s filings submitted to BSE.